GridAI Technologies Corp.
GRDXHealthcare|Biotechnology|GB
$4.92
+0.25 (+5.35%)
Cash / Share
$0.21
Financials
Financial Snapshot
Market Cap
$35.1M
Enterprise Value
$35.5M
Revenue (TTM)
$160.3K
Net Income (TTM)
-$20.5M
Cash & Investments
$1.4M
Net Cash
-$432.2K
Free Cash Flow (TTM)
-$8.1M
Operating CF (TTM)
-$8.1M
Debt/Equity
0.10
Cash Runway & Burn Rate
Cash on Hand
$1.4M
Quarterly Burn
$2.0M
Monthly Burn
$676.7K
Est. Runway
~0.7 quarters
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Investments | $1.8M | $573.5K | $1.1M | $175.8K | $6.1M | $8.2M | $1.4M | $3.7M | $163.5K | $899.8K | $1.4M | |
| Operating Cash Flow | -$4.5M | -$7.2M | -$10.9M | -$14.0K | -$11.2M | -$32.3M | -$22.3M | -$12.4M | -$9.2M | -$5.7M | -$8.1M | |
| Free Cash Flow | -$4.5M | -$7.2M | -$11.2M | -$38.1K | -$11.2M | -$42.6M | -$22.3M | -$12.9M | -$9.2M | -$5.7M | -$8.1M | |
| Capital Expenditure | -$12.4K | -$32.2K | -$305.5K | -$24.1K | -$4.2K | -$10.3M | $0.00 | -$500.0K | $0.00 | $0.00 | $0.00 | |
| Financing Cash Flow | $5.7M | $6.0M | $11.7M | $13.1M | $17.0M | $44.8M | $15.7M | $15.2M | $5.6M | $5.9M | $9.3M |
R&D Spending
R&D (TTM)
$1.5M
R&D Intensity
960.4%
R&D Growth vs Prior
+66.4%
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $36.3K | $160.3K | |
| R&D Expense | $2.5K | $2.4K | $5.8K | $8.7K | $18.6M | $38.3M | $691.3K | $5.0M | $903.94 | $925.5K | $1.5M | |
| R&D % of Revenue | — | — | — | — | — | — | — | — | — | 2553.0% | 960.4% | |
| SG&A | $4.1K | $7.7K | $7.5K | $6.1K | $7.3M | $18.4M | $12.0M | $10.7M | $14.7M | $5.5M | $8.3M |
Income Statement
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $36.3K | $160.3K | |
| Cost of Revenue | $734.5K | $754.0K | $798.4K | $977.0K | $571.1K | $0.00 | $0.00 | $0.00 | $48.9K | $1.3M | $2.6M | |
| Gross Profit | -$734.5K | -$754.0K | -$798.4K | -$977.0K | -$571.1K | $0.00 | $0.00 | $0.00 | -$48.9K | -$1.2M | -$2.5M | |
| R&D | $2.5K | $2.4K | $5.8K | $8.7K | $18.6M | $38.3M | $691.3K | $5.0M | $903.94 | $925.5K | $1.5M | |
| SG&A | $4.1K | $7.7K | $7.5K | $6.1K | $7.3M | $18.4M | $12.0M | $10.7M | $14.7M | $5.5M | $8.3M | |
| Operating Income | -$6.6M | -$10.1M | -$12.8M | -$14.4M | -$26.4M | -$59.1M | -$12.7M | -$15.8M | -$15.6M | -$7.1M | -$12.3M | |
| Interest Expense | $5.9M | $875.2K | $101.8K | $433.9K | $5.8M | $11.2K | $15.9K | $22.5K | $0.00 | $490.8K | $1.3M | |
| Pretax Income | -$14.6M | -$11.1M | -$13.5M | -$15.2M | -$32.7M | -$58.5M | -$14.6M | -$15.8M | -$15.6M | -$6.6M | -$21.8M | |
| Net Income | -$14.6M | -$11.1M | -$13.5M | -$15.2M | -$32.7M | -$58.5M | -$14.6M | -$15.8M | -$18.1M | -$6.4M | -$20.5M | |
| EPS (Diluted) | -94215.17 | -43847.52 | -36815.89 | -28425.72 | -184913.00 | -71686.67 | -1250.82 | -143.64 | -5.33 | -4.16 | -4.31 | |
| EBITDA | -$7.9M | -$9.5M | -$12.6M | -$13.7M | -$25.9M | -$58.0M | -$14.6M | -$15.7M | -$15.6M | -$6.5M | -$10.1M | |
| Shares Out. (M) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.11 | 3.43 | 1.62 | 6.42 |
Balance Sheet
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.8M | $573.5K | $1.1M | $175.8K | $6.1M | $8.2M | $1.4M | $3.7M | $163.5K | $899.8K | $1.4M | |
| Short-Term Investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Total Current Assets | $3.0M | $2.0M | $4.8M | $3.4M | $7.9M | $9.4M | $3.4M | $5.0M | $83.5M | $2.6M | $2.3M | |
| Total Assets | $6.8M | $6.6M | $7.5M | $8.9M | $12.9M | $11.8M | $5.4M | $6.9M | $85.4M | $48.6M | $41.4M | |
| Total Current Liabilities | $2.3M | $2.5M | $3.0M | $4.3M | $15.5M | $12.3M | $2.5M | $3.1M | $27.5M | $15.2M | $14.1M | |
| Long-Term Debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Total Liabilities | $3.5M | $3.8M | $3.0M | $4.3M | $15.6M | $19.6M | $2.7M | $3.3M | $27.6M | $19.7M | $18.3M | |
| Stockholders' Equity | $3.2M | $2.7M | $4.5M | $4.6M | -$2.6M | -$7.8M | $2.7M | $3.6M | $57.8M | $23.7M | $18.3M | |
| Retained Earnings | -$22.9M | -$34.0M | -$47.5M | -$62.7M | -$95.4M | -$153.9M | -$168.5M | -$184.3M | -$202.4M | -$208.8M | -$224.9M |
Cash Flow Statement
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$4.5M | -$7.2M | -$10.9M | -$14.0K | -$11.2M | -$32.3M | -$22.3M | -$12.4M | -$9.2M | -$5.7M | -$8.1M | |
| Capital Expenditure | -$12.4K | -$32.2K | -$305.5K | -$24.1K | -$4.2K | -$10.3M | $0.00 | -$500.0K | $0.00 | $0.00 | $0.00 | |
| Free Cash Flow | -$4.5M | -$7.2M | -$11.2M | -$38.1K | -$11.2M | -$42.6M | -$22.3M | -$12.9M | -$9.2M | -$5.7M | -$8.1M | |
| Investing Cash Flow | -$12.4K | -$32.2K | -$305.5K | -$24.1K | $87.3K | -$10.3M | $0.00 | -$500.0K | $88.2K | $323.5K | $323.5K | |
| Financing Cash Flow | $5.7M | $6.0M | $11.7M | $13.1M | $17.0M | $44.8M | $15.7M | $15.2M | $5.6M | $5.9M | $9.3M | |
| Issuance of Stock | $5.3M | $5.0M | $11.9M | $9.5M | $988.3K | $32.7M | $23.0M | $15.8M | $6.2M | $3.6M | $6.0M | |
| Repurchase of Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Net Debt Issuance | $1.9M | $1.0M | -$190.7K | $3.6M | $2.9M | $88.8K | -$641.2K | -$603.5K | -$644.6K | $3.0M | $3.6M | |
| Stock Based Comp. | $0.00 | $1.1M | $2.5M | $1.4K | $549.4K | $1.4M | $769.1K | $1.0M | $631.6K | $734.0K | $2.1M | |
| Net Change in Cash | $1.2M | -$1.2M | $540.9K | -$938.5K | $5.9M | $2.2M | -$6.9M | $2.3M | -$3.5M | $714.8K | $1.4M |
Dilution Tracker
Shares outstanding grew 715256.2% over 5 years — significant dilution
Shares Outstanding
7M
5-Year Share Growth
+715256.2%
Stock Issuance (TTM)
$6.0M
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Out. (M) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.11 | 3.43 | 1.62 | 6.42 | |
| Change vs Prior % | — | 63.2% | 45.5% | 45.1% | -57.7% | 421.7% | 915.3% | 836.6% | 2963.8% | -52.9% | 297.1% | |
| Stock Issuance | $5.3M | $5.0M | $11.9M | $9.5M | $988.3K | $32.7M | $23.0M | $15.8M | $6.2M | $3.6M | $6.0M | |
| Stock Repurchase | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Stock Based Comp. | $0.00 | $1.1M | $2.5M | $1.4K | $549.4K | $1.4M | $769.1K | $1.0M | $631.6K | $734.0K | $2.1M |
Margins & Profitability
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | — | — | — | — | — | — | — | — | — | -3398.9% | -1532.5% | |
| Operating Margin % | — | — | — | — | — | — | — | — | — | -19540.0% | -7655.4% | |
| Net Margin % | — | — | — | — | — | — | — | — | — | -17634.4% | -12789.6% | |
| EBITDA Margin % | — | — | — | — | — | — | — | — | — | -17954.6% | -6330.4% | |
| FCF Margin % | — | — | — | — | — | — | — | — | — | -15731.5% | -5064.9% | |
| ROE % | -454.1% | -406.2% | -302.5% | -328.7% | 1237.2% | 748.4% | -533.5% | -438.4% | -31.2% | -27.0% | -55.1% | |
| ROA % | -216.0% | -169.4% | -181.2% | -170.5% | -252.8% | -496.5% | -268.9% | -229.5% | -21.1% | -13.2% | -49.5% | |
| ROIC % | -145.0% | -224.6% | -270.5% | -230.9% | 1313.9% | -28282.2% | -349.7% | -356.0% | -27.0% | -18.7% | -40.8% | |
| R&D / Revenue % | — | — | — | — | — | — | — | — | — | 2553.0% | 960.4% |
Growth (Year over Year)
Fiscal years. Rising share count growth means dilution.
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Gross Profit | -0.1% | -2.7% | -5.9% | -22.4% | 41.5% | 100.0% | 0.0% | 0.0% | 0.0% | -2417.4% | |
| Operating Income | -40.1% | -52.2% | -26.9% | -12.3% | -84.0% | -123.4% | 78.5% | -24.4% | 0.9% | 54.7% | |
| Net Income | -146.1% | 24.0% | -22.0% | -12.1% | -115.3% | -79.2% | 75.0% | -8.0% | -14.3% | 64.6% | |
| EPS (Diluted) | -269.8% | 53.5% | 16.0% | 22.8% | -550.5% | 61.2% | 98.3% | 88.5% | 96.3% | 22.0% | |
| Operating Cash Flow | -8.7% | -58.4% | -51.3% | 99.9% | -79865.4% | -187.7% | 30.8% | 44.6% | 25.5% | 38.1% | |
| Free Cash Flow | -8.4% | -58.7% | -54.8% | 99.7% | -29339.8% | -279.6% | 47.6% | 42.4% | 28.4% | 38.1% | |
| R&D Expense | 78.5% | -4.0% | 141.0% | 50.4% | 213920.8% | 106.3% | -98.2% | 628.1% | -100.0% | 102283.0% | |
| SG&A Expense | 24.0% | 86.1% | -3.1% | -18.6% | 120048.8% | 152.4% | -34.8% | -10.4% | 37.1% | -62.6% | |
| Total Assets | 1.0% | -3.0% | 14.0% | 19.2% | 45.2% | -8.8% | -53.9% | 26.5% | 1140.8% | -43.2% | |
| Book Value / Share | 233.1% | -47.9% | 12.6% | -28.9% | -235.1% | 43.2% | 103.5% | -86.0% | -47.6% | 6.0% | |
| Debt | -97.6% | 168.4% | -38.8% | 529.2% | -60.8% | 63.8% | -14.2% | -6.4% | -83.0% | 1510.8% | |
| Diluted Shares | -33.5% | 63.2% | 45.5% | 45.1% | -57.7% | 421.7% | 915.3% | 836.6% | 2963.8% | -52.9% |
Valuation
P/E (TTM)At Loss
P/S218.82
P/B1.72
10Y Low / Med / High0.11 / 12.54 / 42.44
EV/EBITDAAt Loss
EV/Revenue221.52
P/FCFAt Loss
Intrinsic Value Models (per share)
Cash / Share
$0.21
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio | -6.34 | -10.45 | -4.14 | -4.61 | -0.66 | -0.25 | -0.29 | -0.09 | -0.35 | -1.12 | -1.14 | |
| P/S Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 207.82 | 218.82 | |
| P/B Ratio | 28.81 | 42.44 | 12.54 | 15.16 | -10.46 | -2.74 | 1.61 | 0.39 | 0.11 | 0.32 | 1.72 | |
| EV/EBITDA | -11.48 | -12.23 | -4.37 | -5.20 | -0.86 | -0.25 | -0.27 | 0.09 | -0.41 | -1.37 | -3.50 | |
| EV/Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 245.45 | 221.52 |
Analyst Estimates & Quality
Altman Z-Score
-7.74
Distress
Piotroski F-Score
2
Weak
Forward Estimates (consensus)
| Metric | FY2026 | FY2027 | FY2028 |
|---|---|---|---|
| Revenue | $22.3M | $27.5M | $58.1M |
| Net Income | -$8.4M | -$8.0M | $2.2M |
| EPS | $-5.22 | $-4.95 | $1.35 |
| # Analysts (EPS) | 1 | 1 | 1 |